Is a complete ACET research report available?

No complete published report is available for Adicet Bio, Inc. (ACET) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Adicet Bio, Inc. (ACET)

NASDAQ: ACET · USD

$9.06

+0.76 (+9.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ACET analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	95.1M
Net income (ttm)	-108.8M
EPS (ttm)	-$13.3
Shares out	10.5M
Volume	60,657
Beta	1.59
Price target	$34.8	+284.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -108.8M
EPS (ttm): -$13.3
Market cap: 95.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ACET indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000002034
Company name	Adicet Bio, Inc.
Country	United States
Country code	US
Cusip	007002207
Employees	102
Employees Change	-50%
Employees Change Percent	-32.89
Enterprise value	$-32.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US0070022076
Last refreshed	2026-07-31
Market cap	$95.1M
Market cap category	Micro-Cap
Price	$9.06
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	5122
Symbol	ACET
Website	https://www.adicetbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-119.51%
FCF yield	-100.61%
P/B ratio	0.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-108.8M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Profit Per Employee	$-1.1M
ROA	-39.44
Roa5y	-26.79
ROCE	-75.32
ROE	-72.19
Roe5y	-49.67
ROIC	-42.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-19.48%
Cagr3y	-39.83%
Cagr5y	-40.34%
EPS Growth Quarters	3
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$169.4M
Cash	$137.6M
Current Assets	$140.1M
Current Liabilities	$18.3M
Debt	$13.9M
Debt Equity	$0.1
Equity	$140.1M
Interest Coverage	-1,928.8
Liabilities	$29.3M
Long Term Assets	$29.3M
Long Term Liabilities	$11M
Net Cash	$123.7M
Net Cash By Market Cap	$136
Net Cash Growth	-7.82%
Net Debt Equity	$-0.88
Tangible Book Value	$140.1M
Tangible Book Value Per Share	$13.03
WACC	11.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.65
Net Working Capital	$-12.9M
Quick ratio	7.54
Working Capital	$121.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-43.59%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-19.46%
200-day SMA	8.59
3Y total return	-78.22%
50-day SMA	8.26
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.44%
All Time High	349.9
All Time High Change	-97.41%
All Time High Date	2022-11-11
All Time Low	6.01
All Time Low Change	50.75%
All Time Low Date	2026-03-30
ATR	0.53
Beta	1.59
Beta1y	2.02
Beta2y	1.94
Ch YTD	7.6
High	9.11
High52	17.44
High52 Date	2025-10-13
High52ch	-48.04%
Low	8.33
Low52	6.01
Low52 Date	2026-03-30
Low52ch	50.75%
Ma50ch	9.73%
Premarket Change Percent	1.64
Premarket Price	$8.44
Premarket Volume	117
Price vs 200-day SMA	5.51%
RSI	58.88
RSI Monthly	37.32
RSI Weekly	53.51
Sharpe ratio	0.03x
Sortino ratio	0.12
Total Return	-43.59%
Tr YTD	7.6
Tr1m	5.84%
Tr1w	7.6%
Tr3m	18.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	4
Analyst Price Target Top	$43
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.79
Operating Income	$-113.8M
Price target	$34.83
Price Target Change	$284
Price Target Change Top	$375

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,425,840%
Float Percent	70.72%
Net Borrowing	-150,000
Shares Insiders	0.8%
Shares Institutions	37.5%
Shares Out	10,501,069
Shares Qo Q	3.64%
Shares Yo Y	43.59%
Short Float	5.16%
Short Ratio	4.21
Short Shares	3.65

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-104M
Adjusted OCF	-103,729,000
Average Volume	90,628.8x
Bv Per Share	13.03
CAPEX	$-283,000
Ch1m	5.84
Ch1w	7.6
Ch1y	-19.47
Ch3m	18.74
Ch3y	-78.22
Ch5y	-92.44
Ch6m	6.59
Change	9.16%
Change From Open	8.11
Close	8.3
Days Gap	0.96
Depreciation Amortization	6,043,000
Dollar Volume	549,552.4
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-113.8M
EBITDA	$-107.8M
EPS	$-13.35
F Score	1
FCF	$-91.6M
FCF EV Yield	280.8x
FCF Per Share	$-8.73
Financing CF	75,284,000
Fiscal Year End	December
Founded	1,947
Investing CF	24,133,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2025-12-30
Last Split Type	Reverse
Ma150	7.82
Ma150ch	15.86%
Ma20	8.53
Ma20ch	6.28%
Net CF	8,078,000
Next Earnings Date	2026-08-10
Open	8.38
Optionable	Yes
Position In Range	93.59
Ppne	26,364,000
Pre Close	8.3
Price Date	2026-07-30
Ptbv Ratio	0.65
Relative Volume	0.67x
Share Based Comp	12,390,000
Tr6m	6.59%
Us State	Massachusetts
Volume	60,657

Adicet Bio, Inc. (ACET)

Coverage state: Market snapshot only — no published research

Generate the first ACET analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ACET

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACET indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ACET

Frequently asked questions